Althea Group
We are early stage investors. We offer growth capital and strategic advisory.
Investments Include
Seed to Exit
Seed to Exit
Seed to Exit
RxTransparent acquired by
Inmar Intelligence, a
portfolio company of OMERS
Seed
Seed to Exit
Seed to Exit
Intellectual property (IP) management software - Automated trademark docketing
Seed
Seed to Exit
Pre-Seed
Breakthrough Fusogenix gene delivery technology used to combat and treat COVID-19
Pre-Seed
Pre-Seed
Pre-Seed
Remote biofeedback for telehealth providers and patients
Seed
Pre-Seed
Seed
Next generation cancer therapy targeting P53 delivered through a patented proteo-lipid vehicle
Seed
Pre-Seed
Seed
DNA-targeted intervention
to clear senescent cells
Seed
Seed
Seed
Femtech. IoT enabled tracker measures changes in cervical fluid, aiding women's reproductive health
Seed
Seed
Seed
Personalized digestive health. Dieta solves IBS using data and AI
Seed
Seed
Series C, now merged with Ginger
Fintech disrupting asset management distribution
Series C, now merged with Ginger
Series C, now merged with Ginger
Series C, now merged with Ginger
Meditation and mindfulness
Seed to Exit
Series C, now merged with Ginger
Seed to Exit
Financial advisor
transition management
Pre-Seed
Series C, now merged with Ginger
Seed to Exit
Sea Monsters snacks (CPG)